Omer Butt | Vice President, Regulatory Affairs
CytoImmune Therapeutics

Omer Butt, Vice President, Regulatory Affairs, CytoImmune Therapeutics

Appearances:

Advanced Therapies USA 2025 - Day 2 @ 13:00

Chair's Remarks: Omer Butt, VP, Regulatory Affairs, Cytoimmune

Omer Butt, Vice President, Regulatory Affairs, CytoImmune Therapeutics

Advanced Therapies USA 2025 - Day 2 @ 14:05

Panel Discussion: IND preparedness for cell & gene therapies: Overcoming regulatory challenges

Moderator: Omer Butt, Vice President, Regulatory Affairs, CytoImmune Therapeutics

Keith Wonnacott, Vice President Regulatory Affairs, Lexeo Therapeutics

Margareth Jorvid, Board Member, Elicera Therapeutics

Steven Highfill, Director of Product Development, Center for Cellular Engineering, Clinical Center, National Institutes of Health

Hugh Gannon, Associate Director, KSQ Therapeutics, Inc.

Nidhi Kotecha, Program Director, Regulatory Affairs, Gates Institute

Shirley Bartido, Director, Global Regulatory Affairs Oncology Cell Therapy, Takeda

Chien-Tsun Kuan, President / CEO and Co-Founder, ARCE Therapeutics Inc.

last published: 02/Oct/25 12:55 GMT

back to speakers

Get Involved with the Advanced Therapies Congress

To sponsor or exhibit

Natasha Bangle
natasha.bangle@terrapinn.com
+44 20 3545 5515

To speak

Chris Shanks
chris.shanks@terrapinn.com
+44 20 8152 7604